Skip to main content
Clinical Trials/EUCTR2013-000100-41-BE
EUCTR2013-000100-41-BE
Active, not recruiting
Not Applicable

Histological study of the (intravenously injected) Indocyanine Green (ICG)distribution in tumour bearing breasts and in axillary pieces of dissection - Histological distribution of ICG in tumor bearing breast and CALND

Jules Bordet Institute0 sitesFebruary 1, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
breast cancer
Sponsor
Jules Bordet Institute
Status
Active, not recruiting
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 1, 2013
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Patients with histo\-pathological diagnosis of mammary cancer who are
  • candidate for mastectomy with complete axillary node dissection,
  • \- Informed consent form signed.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 10
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • \- Diagnosis of mammary cancer established, either by tumorectomy, or
  • by gross biopsy,
  • \- Operation foreseen after neo\-adjuvant chemotherapy,
  • \- Age less than18 years old.
  • \- In pre\-menopausal women, operation foreseen during the second
  • phase of their cycle,
  • \- Inability to give informed consent.
  • \- History of allergy or hypersensitivity against the investigational
  • product (its active substance or ingredients), to iodine or to shellfish.
  • \- Apparent hyperthyroidism, autonomous thyroid adenoma, unifocal,

Outcomes

Primary Outcomes

Not specified

Similar Trials